In the mild cognitive impairment (MCI) stage, as the disease progresses, the dysregulation of the PI3K/Akt signaling axis and the consequent hyperactivity of GSK3β contribute to the formation of toxic tau species and the accumulation of Aβ. This evidence concerns the gene GSK3B and Cognitive impairment.